Recall Alert: Child-Resistant Packaging Issue with Bayer Afrin Nasal Spray
A popular Bayer sinus medicine is being recalled due to substandard child-resistant packaging that poses a risk of child poisoning. The U.S. Consumer Product Safety Commission has recalled approximately 786,100 travel-size Afrin nasal spray bottles containing imidazoline, as the packaging does not meet federal standards for child protection. The medication was sold for $7 to $9 at convenience stores and travel hubs, including airports, from September 2024 to April 2026.
If you have purchased one of the recalled bottles, it is important to keep it out of the sight and reach of children. You can request a refund on the Bayer website by submitting a photo of the product. After requesting a refund, it is recommended to dispose of the product to prevent any potential harm. Fortunately, no injuries have been reported in connection with this recall.
The affected medication was manufactured in Germany by Bayer Healthcare LLC of Whippany, New Jersey. If you have purchased the recalled Afrin nasal spray, take the necessary steps to ensure the safety of your family and request a refund promptly. Stay informed about product recalls and safety alerts to protect yourself and your loved ones from potential hazards.